10x Genomics Reports Third Quarter 2023 Financial Results

/PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the third quarter ended...

Related Keywords

United States ,Hong Kong ,China ,Serge Saxonov ,Genomics Inc ,Xenium Panel Designer ,Securities Exchange ,Beckman Coulter Life Sciences ,Nasdaq ,Exchange Commission ,Linkedin ,Chromium Single Cell Gene Expression Flex ,Conference Call ,Private Securities Litigation Reform Act ,Securities Act ,Securities Exchange Act ,Financial Condition ,Consolidated Statements ,Middle East ,10x Genomics ,Nc ,Biotechnology ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Earnings ,Earnings Forecasts Amp Projections ,